Objectives-To investigate gestational age-specific serial changes in umbilical vein (UV) volume blood flow during the second half of normal pregnancy and establish sex-specific reference ranges.
T he importance of sex-specific data analysis in research has been much emphasized.
1 Sex differences are important, as they influence perinatal outcomes. [2] [3] [4] A female survival advantage among neonates is well known, 5, 6 but total mortality during pregnancy is greater for female fetuses compared with male fetuses. 7, 8 There are sex-related differences in the structure and function of the human placenta. 9, 10 Girls have smaller placentas 11 and lower birth weight compared with boys. Placental metabolic efficiency expressed in terms of the fetal-to-placental weight ratio 12 is higher in male fetuses, 11 but they may have less reserve capacity. placenta are to be expected between male and female fetuses. There are sex-dependent differences in the global transcriptomic profile in the placenta, with female placentas expressing more up-regulated autosomal genes and some select transcripts, such as the human chorionic gonadotropin. 14 Genetic as well as epigenetic differences may drive sexually dimorphic responses of the placenta to the intrauterine and external environments, leading to disparities in placental perfusion, metabolism, steroidogenesis, growth, and maturation. However, studies on sex-related differences in placental blood flow are scarce.
Sex-specific fetal weight standards are used while evaluating intrauterine growth, 15 and they are reported to be more accurate 16 and better in identifying small-forgestational-age fetuses at risk of stillbirth. 17 However, sex differences are not taken into account when evaluating fetoplacental blood flow characteristics.
The oxygenated nutrient-rich blood is supplied to the fetus via a single umbilical vein (UV). As the umbilical circulation is a closed circuit, UV volume blood flow can be used a proxy for placental perfusion and function. Previous research has shown that reduced UV volume blood flow may be the earliest sign of placental insufficiency, 18 and the fraction of fetal cardiac output directed to the placenta is reduced even before the fetal weight becomes abnormal. 19 In a recent study, Prior et al 20 showed that male fetuses at term had reduced UV volume blood flow compared with female fetuses before the onset of active labor, but this finding was not associated with adverse perinatal outcomes. Both cross-sectional 21 and longitudinal 22 reference standards for UV volume blood flow have been published, but they do not take into account fetal sex differences. Thus, the aim of our study was to test the hypothesis that placental blood flow is different between male and female fetuses by investigating gestational age-specific changes in UV volume blood flow during the second half of normal pregnancy and establish sex-specific longitudinal reference ranges for UV diameter, blood flow velocity, and UV volume blood flow.
Materials and Methods
Data from a total of 183 pregnant women participating in 2 prospective longitudinal observational studies that included investigation of fetoplacental hemodynamics in low-risk pregnancies were used for this study. Women older than 18 years attending their routine sonographic screening at 17 to 20 weeks' gestation were recruited. Gestational age was confirmed by measurement of the biparietal diameter in all cases. The inclusion criteria were singleton pregnancy and no history of hypertensive disorders of pregnancy, intrauterine growth restriction, preterm labor, gestational diabetes, or other maternal disease that may have had any substantial impact on the course and outcome of the current pregnancy. Maternal smoking, multiple pregnancy, and the presence of any chromosomal or major structural fetal anomaly were exclusion criteria. The study protocols were approved by the Regional Committee for Medical Research EthicsNorth Norway (REK Nord 74/2001 and 52/2005). All participants gave written informed consent.
Sonographic examinations were performed by 2 experienced clinicians (G.A. and K.F.) using a 6-MHz curvilinear transducer (Acuson Sequoia 512; Siemens Medical Solutions, Mountain View, CA) at approximately 4-week (range, 3-5 weeks) intervals starting from 19 to 22 weeks until delivery. After determining the fetal viability, position, placental location, and amniotic fluid index, biometry was performed to measure the biparietal diameter, head circumference, abdominal circumference, and femur length, and fetal weight was estimated according to formula 2 of Hadlock et al. 23 Doppler sonography was performed to obtain blood flow velocities from the intra-abdominal portion of the UV. Color Doppler imaging was used to visualize the vessel and direction of blood flow and to optimize the insonation angle, which was always kept below 15 8. Blood flow velocities were recorded by pulsed wave Doppler imaging with a wide sample volume (gate size of 5-12 mm depending on the gestational age) adjusted to include the entire diameter of the insonated blood vessel and the wall motion filter set at low. The UV velocities were recorded in the absence of fetal movements for 4 to 6 seconds with a sweep speed of 50 to 100 mm/s, and the time-averaged maximum velocity was measured by manually tracing the velocity envelope over 2 seconds. The mean velocity was calculated as 0.5 3 time-averaged maximum velocity, assuming a parabolic velocity profile in the intra-abdominal portion of the UV. 22 The inner diameter of the UV was measured at the intra-abdominal straight portion in a zoomed Bmode sonogram. An average of 3 measurements was recorded. The ALARA (as low as reasonably achievable) principle was observed during sonography. The mechanical and thermal indices were displayed on the screen and were always kept below 1.9 and 1.5, respectively. The UV blood flow recording was successful in 694 of 746 (93.03%) observations. The UV volume blood flow was calculated as the product of the mean velocity and cross-sectional area of the UV, where cross-sectional area 5 p (UV diameter/ 2) All included participants received standard care. The sex of the fetus was not examined and not recorded antenatally. The information on the course and outcome of pregnancy, including any complications, gestation at delivery, mode of delivery, birth weight, placental weight, sex of the neonate, Apgar score, umbilical cord blood gases, acid-base status, and neonatal outcome, was obtained from the medical records. All neonates were examined by a pediatrician routinely before discharge.
Data analysis was performed with SAS 9.3 software (SAS Institute Inc, Cary, NC). All variables that were not normally distributed were transformed (logarithmic or power transformation) to achieve a normal distribution of data. The best transformation for each variable was chosen by Box-Cox regression. Regression curves were fitted by fractional polynomials. The best-fitting curves in relation to gestational age were chosen, accommodating nonlinear associations and a repeatedmeasures design. The association of the UV diameter, time-averaged maximum velocity, UV volume blood flow, and normalized UV volume blood flow (dependent variables) with the gestational age (independent variable) was investigated by multilevel modeling. Gestational age-specific reference percentiles were constructed from each fitted model as described by Royston and Altman. 24 Differences between groups (male and female fetuses) with regard to the UV diameter, velocities, and blood flow were evaluated by an independentsamples t test for each gestational week separately. A v 2 test was used for categorical variables. Statistical significance was set at 2-tailed P < .05. The number of study participants required to establish normal reference intervals was estimated to be approximately 180 based on the assumption that about 15 observations per gestational week (ie, a total of 330 observations between 19 and 41 weeks) for each sex would be sufficient to calculate reference intervals with adequate precision. 
Results
Of a total of 183 participants, 4 were excluded (because of a diagnosis of a fetal anomaly or smoking during pregnancy), and complete data were available for analysis for 179 pregnancies. There were 87 male and 92 female fetuses. The baseline demographic and clinical characteristics of the study population, including pregnancy outcomes, are presented in Table 1 . There were no significant differences between groups with regard to maternal characteristics and perinatal outcomes.
A total of 746 observations (356 for male fetuses and 390 for female fetuses) were used to construct sexspecific reference intervals of the UV diameter, timeaveraged maximum velocity, UV volume blood flow, and normalized UV volume blood flow for each gestational week during the second half of pregnancy. The UV diameter, time-averaged maximum velocity, UV volume blood flow, and normalized UV volume blood flow were significantly associated with gestational age (P < .00001). Sex-specific reference ranges for the UV diameter, time-averaged maximum velocity, UV volume blood flow, and normalized UV volume blood flow in the second half of pregnancy are presented in Figures 1  and 2 , and their respective 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95 th , and 97.5th percentiles for each gestational week from 19 to 41 weeks are presented in Tables  2-9 . The gestational age-related sex differences in the time-averaged maximum velocity and normalized UV volume blood flow during the second half of pregnancy are shown in Figures 3 and 4 , respectively.
We found no statistically significant differences in the UV diameter, time-averaged maximum velocity, and absolute or normalized UV volume blood flow between male and female fetuses neither at each gestational week nor when the observations were grouped (<24 weeks, 24-32 weeks, and >32 weeks). The female fetuses started (at mid gestation) with a slightly higher timeaveraged maximum velocity compared with male fetuses, but the values equalized at 26 weeks, with male fetuses having slightly higher UV velocities thereafter until term (Figure 4 ), but the differences were not statistically significant. Although there were no statistically significant differences in quantitative terms, the UV volume blood flow normalized for estimated fetal weight showed an interesting temporal trend (a biphasic pattern), with male fetuses having lower blood flow compared with female fetuses from 20 to 24 weeks, slightly higher flow from 24 to 32 weeks, and then lower flow again from 32 weeks onward (Figure 4 ).
Discussion
Sexual dimorphism in placental weight 11 and certain aspects of placental function have been described, 10, 25 but studies on sex differences in placental blood flow and perfusion are scarce. Longitudinal studies evaluating sexual dimorphism in gestational age-related serial changes in fetoplacental blood flow are lacking. To our knowledge, a study that determined sex-specific reference ranges for UV volume blood flow has not been reported previously. We found no statistically significant differences in UV velocities and blood flow during the second half of normal pregnancy. Despite this finding, a biphasic pattern of serial changes in normalized UV volume blood flow was observed, with crossovers at 24 and 32 weeks' gestation. A sex-related difference in fetoplacental blood flow in human pregnancy was first reported recently by Prior et al, 20 who found significantly lower normalized UV volume blood flow in male fetuses compared with female fetuses at term (56 versus 61 mL/ min/kg; P 5 .02). However, it was a cross-sectional study, and the blood flow measurements were performed on admission to a labor ward; therefore, the women might have been in the latent/early phase of labor.
The main strength of our study was its longitudinal design and reasonable number of observations in each gestational week, which allowed us to construct valid reference charts. The study limitations were related to technical issues associated with accurate estimation of UV volume blood flow. However, volume blood flow measurements using modern ultrasound systems have been shown to be reasonably accurate in experimental settings, 26, 27 and measurements of UV volume blood flow have acceptable accuracy and reproducibility in clinical settings. 28, 29 Furthermore, substantial effort to improve accuracy was made by choosing a fixed and easily identifiable site (ie, the intra-abdominal portion of the UV) for blood flow measurement, measuring the UV diameter 3 times and averaging the values and keeping the Doppler insonation angle as low as possible (<15 8) while recording UV velocities. Another limitation was the lack of observations before 19 weeks' gestation.
The placenta sustains fetal life and also acts as a barrier that protects the fetus from environmental hazards. Poor placental perfusion is associated with placental dysfunction, which can have serious life-long consequences. Edwards et al 30 reported higher rates of severe placental dysfunction in male fetuses, evidenced by absent or reversed end-diastolic flow in the umbilical artery in a cohort of growth-restricted fetuses. The UV blood flow is reduced in placental insufficiency even before the UA Doppler indices become abnormal. 18 Therefore, using sex-specific reference ranges might help improve Sex-specific reference values of the UV diameter at the intra-abdominal section for the 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 97.5th percentiles during the second half of pregnancy (male fetuses). Sex-specific reference values of the UV diameter at the intra-abdominal section for the 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 97.5th percentiles during the second half of pregnancy (female fetuses). Sex-specific reference values of the UV time-averaged maximum velocity at the intra-abdominal section for the 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 97.5th percentiles during the second half of pregnancy (male fetuses). Sex-specific reference values of the UV time-averaged maximum velocity at the intra-abdominal section for the 2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 97.5th percentiles during the second half of pregnancy (female fetuses).
accuracy and precision of the diagnosis of placental insufficiency.
The impact of sex differences on placental pathophysiologic characteristics has become more obvious in recent years. The placenta may respond and adapt differently to pathologic insults in a sex-specific and gestational age-dependent manner. Sexual dimorphism in placental inflammatory, hypoxic, and apoptotic responses and angiogenesis has been observed in preeclamptic placentas, with male fetuses expressing higher levels of tumor necrosis factor a, interleukin 6, interleukin 8, hypoxia-inducible factor 1a, and proapoptotic markers but lower vascular endothelial growth factor compared with female fetuses. 31 Female fetuses born before 72 hours after antenatal betamethasone treatment have greater 11b-hydroxysteroid dehydrogenase activity in the placenta and higher umbilical artery cortisol concentrations compared with male fetuses exposed to a similar treatment. 32 Furthermore, sex-specific alterations in placental genes involved with growth and inflammation have also been observed in cases of maternal hypoxia. 25 Recently, Orzack et al 8 studied the trajectory of the human sex ratio from conception to birth. They found that the sex ratio was unbiased at conception, but a temporal change in the sex ratio was noted, with excess male mortality in the embryonic period (<10 weeks) and third trimester (28-35 weeks), whereas female mortality was higher at 10 to 15 weeks. These observations support the assumption that there is a sex-related bias in placental function, and its growth trajectory during the gestation is influenced by the sex.
A recent study showed that in pregnancies dated by sonography, the male-to-female ratio increased after 40 weeks, reaching 1.69 at 42 weeks. 33 This increase may be because female fetuses are smaller than the male fetuses already at dating, leading to an underestimation of their gestational age, or because male fetuses attain a critical fetal weight earlier than the female fetuses. The sex differences in placental weight are in line with the long-recognized sex differences in fetal growth velocity. 34 Male fetuses have higher absolute placental weight but a greater fetal-to-placental ratio compared with female fetuses, which may suggest higher placental efficiency in male fetuses. However, it can also be interpreted to indicate that male fetuses prioritize body growth at the expense of the placenta, making them more vulnerable to placental dysfunction. As placental metabolism and growth are affected by blood flow, it is plausible that there exists sex-specific dimorphism in placental perfusion and function. However, the differences might not be present throughout the gestation. A previous study reported no sex differences in the human chorionic gonadotropin level in the first and second trimesters, but the maternal serum human chorionic gonadotropin level increased significantly in pregnancies with female fetuses and decreased with male fetuses from the second to third trimesters. 35 A crossover of normalized UV volume blood flow among male and female fetuses at 24 and 32 weeks is an interesting phenomenon. It supports the assumption that the placental maturation is faster in male fetuses, whereas the pulmonary growth and maturation are faster in female fetuses (leading to a higher proportion of fetal right ventricular cardiac output distributed to the lungs at the expense of the placenta). This assumption could be one of the explanations for higher antenatal loss (miscarriage and stillbirth) rates among female fetuses 7, 8 and neonatal mortality rates among male fetuses 5 reported in epidemiologic studies.
In conclusion, there were no statistically significant sex-specific differences in fetoplacental blood flow in quantitative terms during the second half of pregnancy, but the pattern of gestational age-dependent temporal changes in placental volume blood flow may be different between male and female fetuses, with crossovers at 24 and 32 weeks' gestation. These findings may have important physiologic implications with regard to in utero development and maturation of the fetoplacental unit.
